Total Funding
77
60
Total FundingDebt Financing raised
Growth Score
4 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
106525
GVB Biopharma specializes in hemp processing and cannabinoid-based consumer product manufacturing.
Acquired by 
22nd Century Group
- Phillip Swindells: CEO & Co-Founder
- Jack Feldman: President
About the Company
GVB Biopharma specializes in hemp processing and cannabinoid-based consumer product manufacturing. GVB is at the vanguard of the organic cultivation, research, development, and marketing of hemp-based wellness solutions for suppliers, customers, and consumers around the globe. It believes passionately in the powerful, life-enhancing qualities of
CBD and other hemp-based products, and take pride in its research in every facet of hemp cultivation and production.
The company was founded in 2016 and is headquartered in Las Vegas, Nevada.
